The trial is evaluating an investigational cancer vaccine in combination with Keytruda More: IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial Source: News
read moreAntimicrobial resistance is considered one of the top ten global public health threats More: Sandoz opens new antibiotic and biosimilar facilities in Austria and Germany Source: News
read moreEU regulator changes its mind on Mirati’s KRAS inhibitor Krazati with a thumbs-up following initial snub zbecker Fri, 11/10/2023 – 11:21 More: EU regulator changes its mind on Mirati's KRAS inhibitor Krazati with a thumbs-up following initial snub Source: fierce
read moreNovo Nordisk devotes $6B to expanding production as CEO indicates more to come aliu Fri, 11/10/2023 – 10:05 More: Novo Nordisk devotes B to expanding production as CEO indicates more to come Source: fierce
read moreValneva wins race, gaining FDA approval for chikungunya vaccine Ixchiq kdunleavy Fri, 11/10/2023 – 09:16 More: Valneva wins race, gaining FDA approval for chikungunya vaccine Ixchiq Source: fierce
read moreA rare disease is defined as a condition that affects fewer than one in 2,000 people More: SynaptixBio says NHS diagnostic service for rare diseases could be expanded Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals